Plasma Soluble Intercellular Adhesion Molecule 1 Levels Are Increased in Type 2 Diabetic Patients with Nephropathy

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Hormone Research in Paediatrics

• Publication date

  2002-08-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000064664PMID 12207164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-ϰB-dependent

  2000cited by this paper
• Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy

  2000cited by this paper
• High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent.

  2000cited by this paper
• [Diabetic nephropathy--recent advances in its mechanism and treatment].

  1999cited by this paper
• Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus.

  1999cited by this paper
• Increased Expression of Intercellular Adhesion Molecule-1 (ICAM-1) in Diabetic Rat Glomeruli: Glomerular Hyperfiltration Is a Potential Mechanism of ICAM-1 Upregulation

  1997cited by this paper
• Circulating Cell Adhesion Molecule Concentrations in Diabetic Women During Pregnancy

  1997cited by this paper
• Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty.

  1996cited by this paper
• Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus.

  1996cited by this paper
• Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control

  1995cited by this paper
• Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration.

  1995cited by this paper
• Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.

  1995cited by this paper
• Increased Levels of Soluble Adhesion Molecules in Type 2 (Non-Insulin Dependent) Diabetes mellitus Are Independent of Glycaemic Control

  1994cited by this paper
• The Aldose Reductase Controversy

  1994cited by this paper
• Leucocyte-endothelial interactions and regulation of leucocyte migration.

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes.

  1993cited by this paper
• Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance

  1992cited by this paper
• Elevated Levels of Circulating Adhesion Molecules in IDDM Patients and in Subjects at Risk for IDDM

  1992cited by this paper
• Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders.

  1991cited by this paper
• Decreased expression of adhesion molecules on monocytes in recent onset IDDM.

  1991cited by this paper
• Adhesion receptors of the immune system

  1990cited by this paper
• Evidence of Polymorphonuclear Neutrophils (PMN) Activation in Patients With Insulin‐Dependent Diabetes Mellitus

  1987cited by this paper

• The Effect of Autologous Dendritic Cell Immunotherapy on Kidney Function and Endothelial Dysfunction of Patients with Diabetic Kidney Disease (DKD): An Open Label Clinical Trial

  2025cites this paper
• Suramin Affects the Renal VEGF-A/VEGFR Axis in Short-Term Streptozotocin-Induced Diabetes

  2023cites this paper
• Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome

  2023cites this paper
• Endothelial Cells: Potential Novel Regulators of Renal Inflammation.

  2022cites this paper
• Drug-Induced Hyperglycemia as a Potential Contributor to Translational Failure of Uncompetitive NMDA Receptor Antagonists

  2021cites this paper
• Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk

  2021cites this paper
• Potential role of serum fetuin-A in relation with pro-inflammatory, chemokine and adhesion molecules in diabetic kidney disease: a case–control study

  2019cites this paper
• Insulin resistance and clinical outcomes after acute ischemic stroke

  2018cites this paper
• Role of the Immune System in Diabetic Kidney Disease

  2018cites this paper
• Vascular Cell Adhesion Molecule 1, Intercellular Adhesion Molecule 1, and Cluster of Differentiation 146 Levels in Patients with Type 2 Diabetes with Complications

  2017cites this paper
• The role of adhesion molecules and cytokines in patients with diabetic nephropathy

  2016cites this paper
• SIMVASTATIN TREATMENT AMELIORATES DIABETIC TYPE 2 CONDITIONS THROUGH LOWERING THE CONCENTRATION OF PLASMA ICAM LEVELS

  2015influential citation
• Effect of uncontrolled hyperglycemia on levels of adhesion molecules in patients with diabetes mellitus type 2

  2015cites this paper
• The Potential Roles of Superoxide Dismutase, Matrix-Metalloprotinase-9 and Interlukine -18 with the Prevalence and Progression of Type II Diabetes Mellitus

  2015cites this paper
• NOD1 expression is increased in the adipose tissue of women with gestational diabetes.

  2014cites this paper
• Markers of endothelial cell dysfunction are increased in human omental adipose tissue from women with pre-existing maternal obesity and gestational diabetes.

  2014cites this paper
• NOD 1 expression is increased in the adipose tissue of women with gestational diabetes

  2014cites this paper
• Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2013cites this paper
• Diabetic kidney disease and immune modulation.

  2013cites this paper
• The Role of Inflammatory Cytokines in Diabetic Nephropathy: Potential Use as Predictive Markers for Early Detection and Progression

  2013cites this paper
• Inflammation in Diabetic Nephropathy

  2012cites this paper
• Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients.

  2012cites this paper
• Assessing the relationship between admission glucose levels, subsequent length of hospital stay, readmission and mortality.

  2012cites this paper
• Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy.

  2012cites this paper
• Influence of exercise training on ischemic brain injury in type 1 diabetic rats.

  2012cites this paper
• Prestroke Glycemic Control Is Associated With the Functional Outcome in Acute Ischemic Stroke: The Fukuoka Stroke Registry

  2011cites this paper
• Quality of Care and Outcomes in Patients With Diabetes Hospitalized With Ischemic Stroke: Findings From Get With the Guidelines–Stroke

  2010cites this paper
• Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2010cites this paper
• Glulisine Versus Human Regular Insulin in Combination With Glargine in Noncritically Ill Hospitalized Patients With Type 2 Diabetes

  2010cites this paper
• Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy

  2010cites this paper
• Derivation and validation of the Prolonged Length of Stay score in acute stroke patients

  2010cites this paper
• Persistent Hyperglycemia >155 mg/dL in Acute Ischemic Stroke Patients: How Well Are We Correcting It?: Implications for Outcome

  2010cites this paper
• Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association.

  2009cites this paper
• Pathogenic perspectives for the role of inflammation in diabetic nephropathy.

  2009cites this paper
• The Prognostic Value of Capillary Glucose Levels in Acute Stroke: The GLycemia in Acute Stroke (GLIAS) Study

  2009cites this paper
• T-cell cytokine production and endothelial dysfunction in type 2 diabetic patients with nephropathy.

  2009cites this paper
• Costs of Stroke Using Patient-Level Data: A Critical Review of the Literature

  2009cites this paper
• Hyperglycaemia in acute ischaemic stroke is associated with an increased 5-year mortality.

  2009cites this paper
• Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke

  2009cites this paper
• The role of adiponectin in ischemia -reperfusion injury in the type 2 diabetic heart

  2008cites this paper
• A Look at System-Wide Data Collection Processes to Improve Patient Outcomes

  2008cites this paper
• Natural history of blood glucose within the first 48 hours after ischemic stroke

  2008cites this paper
• Economic Benefits of Intensive Insulin Therapy in Critically Ill Patients

  2008cites this paper
• Management of Hyperglycemia in Acute Stroke: How, When, and for Whom?

  2008cites this paper
• Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications

  2008cites this paper
• Treatment of Hyperglycemia In Ischemic Stroke (THIS): A Randomized Pilot Trial

  2008cites this paper
• Role of inflammation in diabetic nephropathy.

  2008cites this paper
• Etiology and effect on outcomes of hyperglycemia in hospitalized patients.

  2007cites this paper
• 特集: 糖尿病性腎症―糖尿病性腎症の成因としての Microinflammation

  2007cites this paper
• Candidate Genes for Late Diabetic Complications

  2007cites this paper
• Guidelines for the Early Management of Adults With Ischemic Stroke

  2007cites this paper
• Laboratory risk factors for hospital mortality in acutely admitted patients.

  2007cites this paper
• IDENTIFICATION OF THE SUSCEPTIBILITY GENES IN TYPE 1 DIABETES AND DIABETIC NEPHROPATHY

  2007cites this paper
• Aberrant Expression of Soluble Co-stimulatory Molecules and Adhesion Molecules in Type 2 Diabetic Patients with Nephropathy

  2007cites this paper
• Diabetes, the Metabolic Syndrome, and Ischemic Stroke

  2007cites this paper
• Identification of the susceptibility genes in type 1 diabets and diabetic nephropathy

  2007cites this paper
• ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice.

  2006cites this paper
• Disorders of glucose metabolism in acute stroke patients: an underrecognized problem.

  2006cites this paper
• Inflammation and diabetic nephropathy

  2006cites this paper
• Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients.

  2006cites this paper
• Therapeutic potential of angiostatin in diabetic nephropathy.

  2006cites this paper
• Hyperglycemia, Insulin, and Acute Ischemic Stroke: A Mechanistic Justification for a Trial of Insulin Infusion Therapy

  2006cites this paper
• Hyperglycemia, insulin and acute ischemic stroke.

  2006cites this paper
• Hyperglycemia After SAH: Predictors, Associated Complications, and Impact on Outcome

  2006cites this paper
• Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test.

  2005cites this paper
• Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

  2005cites this paper
• Part 9: Adult Stroke

  2005cites this paper
• Optimizing Discharge Planning: Clinical Predictors of Longer Stay After Recombinant Tissue Plasminogen Activator for Acute Stroke

  2005cites this paper
• Cardiovascular Disease in Diabetic Nephropathy Patients: Cell Adhesion Molecules as Potential Markers?

  2005cites this paper
• Endothelial Dysfunction, Cellular Adhesion Molecules and the Metabolic Syndrome

  2005cites this paper
• [Markers of vascular inflammation in diabetes mellitus type 2 with hypertension and albuminuria].

  2004cites this paper
• Inpatient diabetes control: approaches to treatment.

  2004cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury.

  2004cites this paper
• Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy

  2004cites this paper
• Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit.

  2004cites this paper
• IV insulin during acute cerebral infarction in diabetic patients

  2004cites this paper
• Hyperglycaemia in patients with acute ischaemic stroke: how often do we screen for undiagnosed diabetes?

  2003cites this paper
• The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage

  2003cites this paper
• Diabetes and nephropathy

  2003cites this paper
• Glucose levels and outcome after subarachnoid hemorrhage

  2003cites this paper
• Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.

  2003cites this paper